Court rejects NHIC’s compensation claim over drugmakers’ improper profit

Published: 2012-01-27 06:57:00

Updated: 2012-01-27 06:57:00

A local court on Friday dismissed a compensation suit filed by the National Health Insurance Corp. against eight pharmaceutical firms for profiteering about 30 billion won.

The NHIC filed the suit, claiming these companies failed to inform their intention to use toll-manufactured raw materials...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK